Table 1. Neonatal Seizures Drug Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Neonatal Seizures Drug Market Restraints

Table 3. Neonatal Seizures Drug Market Trends

Table 4. Neonatal Seizures Drug Industry Policy

Table 5. Global Neonatal Seizures Drug Revenue by Company, 2019-2023, US$ million

Table 6. Global Neonatal Seizures Drug Revenue Market Share by Company, 2019-2023

Table 7. Global Neonatal Seizures Drug Sales Volume by Company, 2019-2023, (K Units)

Table 8. Global Neonatal Seizures Drug Sales Volume Market Share by Company, 2019-2023

Table 9. Global Neonatal Seizures Drug Price by Company, 2019-2023, (US$/Unit)

Table 10. Global Neonatal Seizures Drug Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Neonatal Seizures Drug Mergers & Acquisitions, Expansion Plans

Table 12. Global Neonatal Seizures Drug Manufacturers Product Type

Table 13. China Neonatal Seizures Drug Revenue by Company, 2019-2023, US$ million

Table 14. China Neonatal Seizures Drug Revenue Market Share by Company, 2019-2023

Table 15. China Neonatal Seizures Drug Sales Volume by Company, 2019-2023, (K Units)

Table 16. China Neonatal Seizures Drug Sales Volume Market Share by Company, 2019-2023

Table 17. China Market, Neonatal Seizures Drug Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China Neonatal Seizures Drug Import & Export Trends

Table 19. Main Sources of China Neonatal Seizures Drug Import

Table 20. Export Destination of China Neonatal Seizures Drug

Table 21. Global Headquarters and Manufacturing Base of Neonatal Seizures Drug Manufacturers

Table 22. Global Major Manufacturers, Neonatal Seizures Drug Capacity Expansion and Future Plans

Table 23. Global Neonatal Seizures Drug Production & Forecast by Region, 2019 VS 2023 VS 2030, (K Units)

Table 24. Global Neonatal Seizures Drug Production by Region, 2019-2023, (K Units)

Table 25. Global Neonatal Seizures Drug Production Forecast by Region, 2024-2030, (K Units)

Table 26. Global Key Players of Neonatal Seizures Drug Upstream (Raw Materials)

Table 27. Global Neonatal Seizures Drug Typical Customers

Table 28. Neonatal Seizures Drug Typical Distributors

Table 29. By Type, Global Neonatal Seizures Drug Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million

Table 30. By Application, Global Neonatal Seizures Drug Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million

Table 31. By Region, Global Neonatal Seizures Drug Market Size, 2019 VS 2023 VS 2030, US$ Million

Table 32. By Region, Global Neonatal Seizures Drug Revenue, 2019-2030, US$ Million

Table 33. By Region, Global Neonatal Seizures Drug Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global Neonatal Seizures Drug Revenue & CAGR，2019 VS 2023 VS 2030, US$ Million

Table 35. By Country, Global Neonatal Seizures Drug Revenue, 2019-2030, US$ Million

Table 36. By Country, Global Neonatal Seizures Drug Revenue Market Share, 2019-2030

Table 37. By Country, Global Neonatal Seizures Drug Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global Neonatal Seizures Drug Sales Volume Market Share, 2019-2030

Table 39. Merck KGaA Company Information, Head Office, Market Area and Industry Position

Table 40. Merck KGaA Neonatal Seizures Drug Models, Specifications and Application

Table 41. Merck KGaA Neonatal Seizures Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 42. Merck KGaA Company Profile and Main Business

Table 43. Merck KGaA Recent Developments

Table 44. Eisai Co., Ltd Company Information, Head Office, Market Area and Industry Position

Table 45. Eisai Co., Ltd Neonatal Seizures Drug Models, Specifications and Application

Table 46. Eisai Co., Ltd Neonatal Seizures Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 47. Eisai Co., Ltd Company Profile and Main Business

Table 48. Eisai Co., Ltd Recent Developments

Table 49. AstraZeneca Company Information, Head Office, Market Area and Industry Position

Table 50. AstraZeneca Neonatal Seizures Drug Models, Specifications and Application

Table 51. AstraZeneca Neonatal Seizures Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 52. AstraZeneca Company Profile and Main Business

Table 53. AstraZeneca Recent Developments

Table 54. Sanofi Company Information, Head Office, Market Area and Industry Position

Table 55. Sanofi Neonatal Seizures Drug Models, Specifications and Application

Table 56. Sanofi Neonatal Seizures Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 57. Sanofi Company Profile and Main Business

Table 58. Sanofi Recent Developments

Table 59. Novartis AG Company Information, Head Office, Market Area and Industry Position

Table 60. Novartis AG Neonatal Seizures Drug Models, Specifications and Application

Table 61. Novartis AG Neonatal Seizures Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 62. Novartis AG Company Profile and Main Business

Table 63. Novartis AG Recent Developments

Table 64. Abbott Company Information, Head Office, Market Area and Industry Position

Table 65. Abbott Neonatal Seizures Drug Models, Specifications and Application

Table 66. Abbott Neonatal Seizures Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 67. Abbott Company Profile and Main Business

Table 68. Abbott Recent Developments

Table 69. F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position

Table 70. F. Hoffmann-La Roche Ltd Neonatal Seizures Drug Models, Specifications and Application

Table 71. F. Hoffmann-La Roche Ltd Neonatal Seizures Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 72. F. Hoffmann-La Roche Ltd Company Profile and Main Business

Table 73. F. Hoffmann-La Roche Ltd Recent Developments

Table 74. Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position

Table 75. Teva Pharmaceutical Industries Ltd Neonatal Seizures Drug Models, Specifications and Application

Table 76. Teva Pharmaceutical Industries Ltd Neonatal Seizures Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 77. Teva Pharmaceutical Industries Ltd Company Profile and Main Business

Table 78. Teva Pharmaceutical Industries Ltd Recent Developments

Table 79. Pfizer Inc Company Information, Head Office, Market Area and Industry Position

Table 80. Pfizer Inc Neonatal Seizures Drug Models, Specifications and Application

Table 81. Pfizer Inc Neonatal Seizures Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 82. Pfizer Inc Company Profile and Main Business

Table 83. Pfizer Inc Recent Developments

Table 84. GlaxoSmithKline plc Company Information, Head Office, Market Area and Industry Position

Table 85. GlaxoSmithKline plc Neonatal Seizures Drug Models, Specifications and Application

Table 86. GlaxoSmithKline plc Neonatal Seizures Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 87. GlaxoSmithKline plc Company Profile and Main Business

Table 88. GlaxoSmithKline plc Recent Developments

Table 89. WOCKHARDT Company Information, Head Office, Market Area and Industry Position

Table 90. WOCKHARDT Neonatal Seizures Drug Models, Specifications and Application

Table 91. WOCKHARDT Neonatal Seizures Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 92. WOCKHARDT Company Profile and Main Business

Table 93. WOCKHARDT Recent Developments

Table 94. Novo Nordisk A/S Company Information, Head Office, Market Area and Industry Position

Table 95. Novo Nordisk A/S Neonatal Seizures Drug Models, Specifications and Application

Table 96. Novo Nordisk A/S Neonatal Seizures Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 97. Novo Nordisk A/S Company Profile and Main Business

Table 98. Novo Nordisk A/S Recent Developments

Table 99. Glenmark Pharmaceuticals Limited Company Information, Head Office, Market Area and Industry Position

Table 100. Glenmark Pharmaceuticals Limited Neonatal Seizures Drug Models, Specifications and Application

Table 101. Glenmark Pharmaceuticals Limited Neonatal Seizures Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 102. Glenmark Pharmaceuticals Limited Company Profile and Main Business

Table 103. Glenmark Pharmaceuticals Limited Recent Developments

Table 104. Cipla Inc Company Information, Head Office, Market Area and Industry Position

Table 105. Cipla Inc Neonatal Seizures Drug Models, Specifications and Application

Table 106. Cipla Inc Neonatal Seizures Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 107. Cipla Inc Company Profile and Main Business

Table 108. Cipla Inc Recent Developments

Table 109. Bausch Health Companies Inc Company Information, Head Office, Market Area and Industry Position

Table 110. Bausch Health Companies Inc Neonatal Seizures Drug Models, Specifications and Application

Table 111. Bausch Health Companies Inc Neonatal Seizures Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 112. Bausch Health Companies Inc Company Profile and Main Business

Table 113. Bausch Health Companies Inc Recent Developments

Table 114. Otsuka America Pharmaceutical, Inc Company Information, Head Office, Market Area and Industry Position

Table 115. Otsuka America Pharmaceutical, Inc Neonatal Seizures Drug Models, Specifications and Application

Table 116. Otsuka America Pharmaceutical, Inc Neonatal Seizures Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 117. Otsuka America Pharmaceutical, Inc Company Profile and Main Business

Table 118. Otsuka America Pharmaceutical, Inc Recent Developments

Table 119. Johnson & Johnson Private Limited Company Information, Head Office, Market Area and Industry Position

Table 120. Johnson & Johnson Private Limited Neonatal Seizures Drug Models, Specifications and Application

Table 121. Johnson & Johnson Private Limited Neonatal Seizures Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 122. Johnson & Johnson Private Limited Company Profile and Main Business

Table 123. Johnson & Johnson Private Limited Recent Developments

Table 124. Takeda Pharmaceutical Company Limited Company Information, Head Office, Market Area and Industry Position

Table 125. Takeda Pharmaceutical Company Limited Neonatal Seizures Drug Models, Specifications and Application

Table 126. Takeda Pharmaceutical Company Limited Neonatal Seizures Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 127. Takeda Pharmaceutical Company Limited Company Profile and Main Business

Table 128. Takeda Pharmaceutical Company Limited Recent Developments

Table 129. Sumitomo Corporation Company Information, Head Office, Market Area and Industry Position

Table 130. Sumitomo Corporation Neonatal Seizures Drug Models, Specifications and Application

Table 131. Sumitomo Corporation Neonatal Seizures Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 132. Sumitomo Corporation Company Profile and Main Business

Table 133. Sumitomo Corporation Recent Developments

Table 134. Biocon Company Information, Head Office, Market Area and Industry Position

Table 135. Biocon Neonatal Seizures Drug Models, Specifications and Application

Table 136. Biocon Neonatal Seizures Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 137. Biocon Company Profile and Main Business

Table 138. Biocon Recent Developments

List of Figure

Figure 1. Neonatal Seizures Drug Picture

Figure 2. By Revenue, Global Neonatal Seizures Drug Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global Neonatal Seizures Drug Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global Neonatal Seizures Drug Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China Neonatal Seizures Drug Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China Neonatal Seizures Drug Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China Neonatal Seizures Drug Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China Neonatal Seizures Drug Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China Neonatal Seizures Drug Share of Global Market, 2019-2030

Figure 10. Global Neonatal Seizures Drug Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 11. Global Neonatal Seizures Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2023

Figure 12. China Neonatal Seizures Drug Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 13. China Neonatal Seizures Drug Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 14. China Neonatal Seizures Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2023

Figure 15. Chinese Local Players, Proportion of Neonatal Seizures Drug Domestic VS Export, 2023

Figure 16. Global Neonatal Seizures Drug Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global Neonatal Seizures Drug Capacity Market Share by Region, 2023 VS 2030

Figure 18. Global Neonatal Seizures Drug Production Market Share & Forecast by Region, 2019-2030

Figure 19. Neonatal Seizures Drug Industry Chain

Figure 20. Neonatal Seizures Drug Procurement Model

Figure 21. Neonatal Seizures Drug Sales Model

Figure 22. Neonatal Seizures Drug Sales Channels, Direct Sales and Distribution

Figure 23. Dilantin

Figure 24. Phenobarbital

Figure 25. Other

Figure 26. By Type, Global Neonatal Seizures Drug Revenue, 2019-2030, US$ Million

Figure 27. By Type, Global Neonatal Seizures Drug Revenue Market Share, 2019-2030

Figure 28. By Type, Global Neonatal Seizures Drug Sales Volume, 2019-2030, (K Units)

Figure 29. By Type, Global Neonatal Seizures Drug Sales Volume Market Share, 2019-2030

Figure 30. By Type, Global Neonatal Seizures Drug Price, 2019-2030, (US$/Unit)

Figure 31. Tonic Seizures

Figure 32. Clonic and Myoclonic Seizures

Figure 33. Non Paroxysmal Repetitive Behaviours

Figure 34. Other

Figure 35. By Application, Global Neonatal Seizures Drug Revenue, 2019-2030, US$ Million

Figure 36. By Application, Global Neonatal Seizures Drug Revenue Market Share, 2019-2030

Figure 37. By Application, Global Neonatal Seizures Drug Sales Volume, 2019-2030, (K Units)

Figure 38. By Application, Global Neonatal Seizures Drug Sales Volume Market Share, 2019-2030

Figure 39. By Application, Global Neonatal Seizures Drug Price, 2019-2030, (US$/Unit)

Figure 40. By Region, Global Neonatal Seizures Drug Revenue Market Share, 2019-2030

Figure 41. By Region, Global Neonatal Seizures Drug Sales Volume Market Share, 2019-2030

Figure 42. North America Neonatal Seizures Drug Revenue & Forecasts, 2019-2030, US$ Million

Figure 43. By Country, North America Neonatal Seizures Drug Revenue Market Share, 2023

Figure 44. Europe Neonatal Seizures Drug Revenue & Forecasts, 2019-2030, US$ Million

Figure 45. By Country, Europe Neonatal Seizures Drug Revenue Market Share, 2023

Figure 46. Asia Pacific Neonatal Seizures Drug Revenue & Forecasts, 2019-2030, US$ Million

Figure 47. By Country/Region, Asia Pacific Neonatal Seizures Drug Revenue Market Share, 2023

Figure 48. South America Neonatal Seizures Drug Revenue & Forecasts, 2019-2030, US$ Million

Figure 49. By Country, South America Neonatal Seizures Drug Revenue Market Share, 2023

Figure 50. Middle East & Africa Neonatal Seizures Drug Revenue & Forecasts, 2019-2030, US$ Million

Figure 51. U.S. Neonatal Seizures Drug Sales Volume, 2019-2030, (K Units)

Figure 52. By Company, U.S. Neonatal Seizures Drug Market Share, 2023

Figure 53. By Type, U.S. Neonatal Seizures Drug Sales Volume Market Share, 2023 VS 2030

Figure 54. By Application, U.S. Neonatal Seizures Drug Sales Volume Market Share, 2023 VS 2030

Figure 55. Europe Neonatal Seizures Drug Sales Volume, 2019-2030, (K Units)

Figure 56. By Company, Europe Neonatal Seizures Drug Market Share, 2023

Figure 57. By Type, Europe Neonatal Seizures Drug Sales Volume Market Share, 2023 VS 2030

Figure 58. By Application, Europe Neonatal Seizures Drug Sales Volume Market Share, 2023 VS 2030

Figure 59. China Neonatal Seizures Drug Sales Volume, 2019-2030, (K Units)

Figure 60. By Company, China Neonatal Seizures Drug Market Share, 2023

Figure 61. By Type, China Neonatal Seizures Drug Sales Volume Market Share, 2023 VS 2030

Figure 62. By Application, China Neonatal Seizures Drug Sales Volume Market Share, 2023 VS 2030

Figure 63. Japan Neonatal Seizures Drug Sales Volume, 2019-2030, (K Units)

Figure 64. By Company, Japan Neonatal Seizures Drug Market Share, 2023

Figure 65. By Type, Japan Neonatal Seizures Drug Sales Volume Market Share, 2023 VS 2030

Figure 66. By Application, Japan Neonatal Seizures Drug Sales Volume Market Share, 2023 VS 2030

Figure 67. South Korea Neonatal Seizures Drug Sales Volume, 2019-2030, (K Units)

Figure 68. By Company, South Korea Neonatal Seizures Drug Market Share, 2023

Figure 69. By Type, South Korea Neonatal Seizures Drug Sales Volume Market Share, 2023 VS 2030

Figure 70. By Application, South Korea Neonatal Seizures Drug Sales Volume Market Share, 2023 VS 2030

Figure 71. Southeast Asia Neonatal Seizures Drug Sales Volume, 2019-2030, (K Units)

Figure 72. By Company, Southeast Asia Neonatal Seizures Drug Market Share, 2023

Figure 73. By Type, Southeast Asia Neonatal Seizures Drug Sales Volume Market Share, 2023 VS 2030

Figure 74. By Application, Southeast Asia Neonatal Seizures Drug Sales Volume Market Share, 2023 VS 2030

Figure 75. India Neonatal Seizures Drug Sales Volume, 2019-2030, (K Units)

Figure 76. By Company, India Neonatal Seizures Drug Market Share, 2023

Figure 77. By Type, India Neonatal Seizures Drug Sales Volume Market Share, 2023 VS 2030

Figure 78. By Application, India Neonatal Seizures Drug Sales Volume Market Share, 2023 VS 2030

Figure 79. Middle East & Asia Neonatal Seizures Drug Sales Volume, 2019-2030, (K Units)

Figure 80. By Company, Middle East & Asia Neonatal Seizures Drug Market Share, 2023

Figure 81. By Type, Middle East & Asia Neonatal Seizures Drug Sales Volume Market Share, 2023 VS 2030

Figure 82. By Application, Middle East & Asia Neonatal Seizures Drug Sales Volume Market Share, 2023 VS 2030

Figure 83. Research Methodology

Figure 84. Breakdown of Primary Interviews

Figure 85. Bottom-up Approaches

Figure 86. Top-down Approaches